Antacids Market Growth, Key Players, and Future Outlook (2024 – 2032)

The global antacids market is expected to grow from USD 7 billion in 2022 to over USD 9.64 billion by 2032, at a CAGR of 3.3% from 2023 to 2032, driven by rising GERD cases and easy access to OTC medications.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5079

Recent Developments in the Antacids Market

• Wonderbelly’s Launch (June 2022): An innovative startup based in Austin, Wonderbelly introduced a line of chewable antacids available over-the-counter. These tablets are designed without parabens, preservatives, talc, or sugar, making them a healthier option for consumers. They are also vegan and free from genetically modified organisms (GMO), appealing to health-conscious individuals looking for more natural remedies for heartburn.
• Sanofi and Roche Partnership (2021): In 2021, pharmaceutical giants Sanofi and Roche joined forces to develop and market a new antacid aimed at treating gastroesophageal reflux disease (GERD). This partnership is expected to bring new treatment options to the market, addressing the growing demand for effective GERD solutions.
• Johnson & Johnson’s Pepcid Complete (2021): Johnson & Johnson released Pepcid Complete in 2021, a dual-action antacid that combines calcium carbonate with famotidine, an acid reducer. This combination is designed to provide quick and long-lasting relief from heartburn symptoms, giving consumers an effective over-the-counter option to manage their digestive health.

Key Companies in the Antacids Market

Here is an overview of the key companies driving the global antacids market:

• Bayer AG: Bayer is a global pharmaceutical and healthcare company based in Germany. They offer a wide range of healthcare products, including antacids under the Alka-Seltzer brand. Bayer focuses on health and wellness products with an emphasis on digestive health, which includes antacids for heartburn relief.
• GlaxoSmithKline Plc.: Based in the UK, GSK is a multinational pharmaceutical and consumer healthcare company. It produces well-known over-the-counter medications, including antacids like Tums and Rolaids. GSK is committed to providing innovative products for digestive health and pain relief.
• Takeda Pharmaceutical Company Ltd.: A leading Japanese pharmaceutical company, Takeda has a strong portfolio in gastrointestinal health. They offer antacids and other treatments for conditions like GERD and ulcers. Their Tums and Maalox brands are widely recognized.
• Sun Pharmaceutical Industries Ltd.: Sun Pharma, based in India, is one of the largest global pharmaceutical companies. They produce antacids like Seltzer and Pepcid, along with a variety of other medications for digestive and other health conditions. Their strong focus on affordability has made their products accessible to a wide range of consumers.
• Dr. Reddy’s Laboratories Ltd.: An Indian multinational, Dr. Reddy’s is known for producing generic pharmaceutical products, including antacids. Their offerings include over-the-counter treatments such as Tums and Zantac that provide relief for heartburn and other gastric issues.
• Pfizer Inc.: A U.S.-based pharmaceutical leader, Pfizer is known for its innovative medicines and consumer healthcare products. Their antacid portfolio includes products like Prevacid and Rolaids, aimed at providing relief for acid reflux and indigestion.
• Reckitt Benckiser Group Plc.: A British multinational, Reckitt Benckiser is a major player in consumer health. They manufacture the popular antacid brands Maalox and Gaviscon. These products are well-known for treating heartburn, acid reflux, and indigestion.
• Cipla Ltd.: A global pharmaceutical company based in India, Cipla produces a wide range of generic medicines, including antacids for heartburn and acid reflux. Their portfolio includes popular OTC brands for digestive health.
• Alkem Laboratories Ltd.: Based in India, Alkem is a major producer of generic pharmaceutical products, including antacids. The company is committed to providing affordable treatments for gastrointestinal conditions.
• Abbott Laboratories: Abbott is a U.S.-based global healthcare company, known for a broad range of products in pharmaceuticals, diagnostics, and nutrition. Their Mylanta brand is well-known for its fast-acting antacid formulations that help with indigestion and acid reflux.

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/antacids-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5079

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Visit Dental Specifics: https://www.towardsdental.com

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare